Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10Esophageal Neoplasms 5Colorectal Neoplasms 5Rectal Neoplasms 4Esophageal Squamous Cell Carcinoma 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma Of Esophagus 4Sarcoma 3Lung Neoplasms 3Uterine Cervical Neoplasms 2Pancreatic Neoplasms 2Osteosarcoma 2Neoplasms 2Melanoma 2Vomiting 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Nausea 1Multiple Myeloma 1Malignant mesenchymal tumor 1

Interventions

Dexamethasone 6fosaprepitant 4Calcium Dobesilate 4Aprepitant 4dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Palonosetron 2Ondansetron 2Granisetron 2Cisplatin 2dolasetron 1casopitant 1Surveys and Questionnaires 1Sugars 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Platinum 1Neoadjuvant Therapy 1Methadone 1Lorazepam 1Interviews as Topic 1Immunoenzyme Techniques 1Esomeprazole 1Diphenhydramine 1Cyproheptadine 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Vomiting × Neoadjuvant Therapy × Clear all
NCT01031953 2017-05-09

Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy

OHSU Knight Cancer Institute

Phase 1/2 Terminated
34 enrolled 12 charts

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡